[Cutaneous reactions to thiacetazone (TB1) (author's transl)].
Twelve cases of cutaneous reactions to TB1 (Thiacetazone associated with isoniazid) occurring on tuberculous black patients are reported: 8 of them are severe reactions (one Lyell's syndrome with fatal outcome). The different patterns of cutaneous side effects of Thiacetazone are reviewed.
D000328:Adult; D000368:Aged; D000505:Alopecia / Q000139:chemically induced; D003875:Drug Eruptions / Q000209:etiology*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010859:Pigmentation Disorders / Q000139:chemically induced; D013280:Stomatitis / Q000139:chemically induced; D013307:Streptomycin / Q000627:therapeutic use; D013828:Thioacetazone / Q000009:adverse effects* / Q000627:therapeutic use; D014376:Tuberculosis / Q000188:drug therapy
D013828:Thioacetazone; D007538:Isoniazid; D013307:Streptomycin
Toxidermies à la thiacétazone (TB1).